| Name | (2R)-2-Hydroxy-N-[2-(4-nitrophenyl)ethyl]-2-phenylacetamide |
|---|---|
| Synonyms |
BenzeneacetaMide, a-hydroxy-N-[2-(4-nitrophenyl)ethyl]
Mirabeon INT 1 ALPHA-Hydroxy-N-[2-(4-nitrophenyl)ethyl]benzamide BenzeneacetaMide, -hydroxy-N-[2-(4-nitrophenyl)ethyl]-, (R) (ALPH-ALPHA-hydroxy-N-[2-(4-nitrophenyl)ethyl]phenylacetamide (R) Alpha hydroxy-N - [2- (4-nitrophenyl) ethyl] phenylacetamide Lactose Impurity 13 (Alph -α-hydroxy-N - [2- (4-nitrophenyl) ethyl] phenylacetamide Mirabeon Impurity 8 (Mirabeon stage -I Impurity ) (R)-N-(4-nitrophenethyl)-2-hydroxy-2-phenylacetamide (R) -2- hydroxy -N- [2- (4- nitrophenyl) ethyl] -2-phenylacetamide (alph-alpha-Hydroxy-N-[2-(4-nitrophenyl)ethyl]benzeneacetamide Mirabeon Impurity 89 (Mirabeon Impurity G) Mirabeon impurity G CRS (R) -N- (4-Nitrophenylethyl) -2-hydroxy-2-phenylacetamide (R)-2-Hydroxy-N-(4-nitrophenethyl)-2-phenylacetamide 2-hydroxy-N-(4-nitrophenethyl)-2-phenylacetamide R-2-((4-aminophenethyl)amino)-1-phenylethan-1-ol hydrochloride High purity (alph-alpha-Hydroxy-N-[2-(4-nitrophenyl)ethyl]benzeneacetamide in stock R-a-hydroxy-N-[2-(4-nitrophenyl)ethyl]- BenzeneacetaMide a-Hydroxy-N-[2-(4-nitrophenyl)ethyl]benzeneacetamide R-alpha-hydroxy-N-[2-(4-nitrophenyl)ethyl]- BenzeneacetaMide |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 584.8±50.0 °C at 760 mmHg |
| Molecular Formula | C16H16N2O4 |
| Molecular Weight | 300.309 |
| Flash Point | 307.5±30.1 °C |
| Exact Mass | 300.110992 |
| PSA | 98.64000 |
| LogP | 2.29 |
| Vapour Pressure | 0.0±1.7 mmHg at 25°C |
| Index of Refraction | 1.618 |
| Storage condition | 2-8°C |
| Hazard Codes | Xi |
|---|
|
~%
521284-19-5 |
| Literature: YAMANOUCHI PHARMACEUTICAL CO. LTD. Patent: EP1440969 A1, 2004 ; Location in patent: Page 5-6 ; |
| Precursor 2 | |
|---|---|
| DownStream 0 | |